Machine-learning and mechanistic modeling of metastatic breast cancer after neoadjuvant treatment
Sébastien Benzekry(Centre National de la Recherche Scientifique), John M.L. Ebos(Roswell Park Comprehensive Cancer Center)
Cited by 19
Related Papers
Enhanced efficacy of sitravatinib in metastatic models of antiangiogenic therapy resistance
|PLoS ONE|2019|29
Acquired resistance to PD-L1 inhibition is associated with an enhanced type I IFN-stimulated secretory program in tumor cells
|bioRxiv (Cold Spring Harbor Laboratory)|2021|1